An Opioid Quality Metric Based on Dose Alone? 80 Professionals Respond to NCQA by Dr. Stefan Kertesz
Efforts to reduce prescribing while optimizing care for patients with pain, and expanding access to addiction treatment, are of cardinal importance.
How we advance these objectives depends partly on changing our shared understandings of what it means to deliver good care. It also depends on policies, resources and formal methods to assess if we are doing a good job.
Dr. Kertesz points out that all these new restrictions aren’t based on any studies at all. Nor are any studies planned to investigate the effect of these new policies. Continue reading
Proven Long-term Opioid Pain Relief:
No Tolerance or Hyperalgesia
I found 5 NIH PubMed articles on the new extended-release hydrocodone pill, Hysingla ER, that prove effective long-term (up to one year) pain relief from an opioid.
Additionally, this is achieved without tolerance or hyperalgesia (the boogeymen of anti-opioid scaremongering).
These studies, undertaken to prove the efficacy of Hysingla ER, also prove that once titrated to an effective dose, patients did not develop tolerance. They found the same doses effective all year. Continue reading
Chronic Pain Harms The Brain — ScienceDaily — February 6, 2008
This article isn’t new and I’ve posted it before, but it’s a classic, providing scientific evidence of the damage done to our brains by uncontrolled chronic pain. We can use it to argue against the anti-opioid articles that claim addiction is much more serious than chronic pain.
National Institutes of Health Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain | Position Papers | February 2015
Not once is the effectiveness of opioids for pain management discussed.
By delving only into the dangers of use, not of the benefits, this gives an unrealistic picture of how opioids are used in medicine.
During the 1.5-day workshop, invited experts discussed the body of evidence.
After weighing evidence from the evidence report, expert presentations, and public comments, an unbiased, independent panel prepared a draft report that identified research gaps and future research priorities. The report was posted on the ODP Web site for 2 weeks for public comment. Continue reading
CDC Scientists Expose Agency Corruption – Nov. 21, 2016 – Robert F. Kennedy, Jr.
Last month, The Hill published a letter [see below] sent by “more than a dozen” senior Center for Disease Control (CDC) scientists charging the agency with nursing an atmosphere of pervasive research fraud.
The letter to CDC Chief of Staff, Carmen Villar, expressed alarm “about the current state of ethics at our agency.”
The scientists complained that “our mission is being influenced and shaped by outside parties and rogue interests” and “circumvented by some of our leaders.”
The scientists told Villar that, “questionable and unethical practices, occurring at all levels and in all of our respective units, threaten to undermine our credibility and reputation as a trusted leader in public health.” Continue reading
Durations of Opioid, Nonopioid Drug, and Behavioral Clinical Trials for Chronic Pain: Adequate or Inadequate?
This commentary presents the case that the CDC manipulated the data it used as a basis for its opioid prescribing guidelines.
By imposing an arbitrary non-standard constraint and excluding some studies that were included in earlier reports, the CDC created a different interpretation by using a different set of data.
Objectives. A recent US federal review and clinical guideline on opioids for chronic pain asserted that the literature contributes no evidence on efficacy because all trials had “inadequate duration.”
To explore the evidence, we examined durations of studies on opioid, nonopioid drug, and behavioral therapies for chronic pain. Continue reading
Turning the Tide or Riptide? the Changing Opioid Epidemic – Stefan G. Kertesz – 18 Nov 2016
This rigorously sourced paper illustrates the absurdity and futility of the crackdown on prescribed pain medication.
Dr. Kertesz meticulously lays out the facts (backed by 50 references to scientific research) proving that opioid prescriptions to patients are not the primary driver of the increasing numbers of overdose deaths.
Restricting such prescriptions has only caused a crisis of untreated pain while doing absolutely nothing to treat the addiction and abuse at the root of most overdoses.
The US opioid epidemic has changed profoundly in the last 3 years, in ways that require substantial recalibration of the US policy response.
Here is a collection of my posts from various sources with basic information about the issues surrounding the opioid “crisis”.
Neat, Plausible, and Generally Wrong: A Response to the CDC Recommendations for Chronic Opioid Use – Medium
Stephen A. Martin, MD, EdM; Ruth A. Potee, MD, DABAM ; and Andrew Lazris, MD
Finally, someone is standing up for the truth about opioids and pain patients. These three courageous M.D.s expose the CDC guidelines for the fraud they are.
They’ve written a well-researched paper that refutes the basis of these unscientific and biased guidelines piece by piece with real evidence from scientific studies to back their claims.
I admire these three authors for having the ethics-based courage not to let this gross misinterpretation of science and be accepted without question.
They show how the CDC cherry-picked data with obvious bias (much as they did people). Repeatedly, the CDC interpreted studies with such a slanted view as to assure the outcome they wanted. Continue reading
5 Myths About the CDC Opioid Guidelines – Aug 2016 – By Pat Anson, Editor
In a recent survey of nearly 2,000 pain patients, over two-thirds said their opioid medication has either been reduced or stopped by their doctor since the CDC’s opioid prescribing guidelines were released.
…a sign they are being rigidly adopted and implemented by physicians, regardless of the impact on patients.
Myth #1: The CDC prescribing guidelines are mandatory
False. The guidelines are voluntary and intended only for primary care physicians, yet they are being widely implemented by many prescribers, including pain management specialists and even some oncologists. Here is what the guidelines actually say: Continue reading